Abstract:Background-beta-Adrenergic stimulation is the main trigger for cardiac events in type 1 long-QT syndrome (LQT1). We evaluated a possible association between ion channel response to beta-adrenergic stimulation and clinical response to beta-blocker therapy according to mutation location.Methods and Results-The study sample comprised 860 patients with genetically confirmed mutations in the KCNQ1 channel. Patients were categorized into carriers of missense mutations located in the cytoplasmic loops (C loops), membrane-spanning domain, C/N terminus, and nonmissense mutations. There were 27 aborted cardiac arrest and 78 sudden cardiac death events from birth through 40 years of age. After multivariable adjustment for clinical factors, the presence of C-loop mutations was associated with the highest risk for aborted cardiac arrest or sudden cardiac death (hazard ratio versus nonmissense mutations = 2.75; 95% confidence interval, 1.29-5.86; P=0.009). beta-Blocker therapy was associated with a significantly greater reduction in the risk of aborted cardiac arrest or sudden cardiac death among patients with C-loop mutations than among all other patients (hazard ratio=0.12; 95% confidence interval, 0.02-0.73; P=0.02; and hazard ratio=0.82; 95% confidence interval, 0.31-2.13; P=0.68, respectively; P for interaction=0.04). Cellular expression studies showed that membrane spanning and C-loop mutations produced a similar decrease in current, but only C-loop mutations showed a pronounced reduction in channel activation in response to beta-adrenergic stimulation.Conclusions-Patients with C-loop missense mutations in the KCNQ1 channel exhibit a high risk for life-threatening events and derive a pronounced benefit from treatment with beta-blockers. Reduced channel activation after sympathetic activation can explain the increased clinical risk and response to therapy in patients with C-loop mutations. (Circulation. 2012; 125: 1988-1996.)

An LQT2-related mutation in the voltage-sensing domain is involved in switching the gating polarity of hERG

Electrophysiological Characteristics of the LQT2 Syndrome Mutation KCNH2-G572S and Regulation by Accessory Protein KCNE2

A Novel Splice Mutation of HERG in a Chinese Family with Long QT Syndrome.

Long QT Syndrome-associated Mutations in the Per-Arnt-Sim (PAS) Domain of HERG Potassium Channels Accelerate Channel Deactivation

Locking hERG channels into place: Using photoreactive unnatural amino acids to study voltage gating

Structural basis for hyperpolarization-dependent opening of human HCN1 channel

Three Novel Mutations of Potassium Channel HERG and SCN5A in Chinese Families of Congenital Long QT Syndromes

Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4.

Structural Mechanisms for the Activation of Human Cardiac KCNQ1 Channel by Electro-Mechanical Coupling Enhancers

Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome

Correction of Defective Protein Trafficking of a Mutant HERG Potassium Channel in Human Long QT Syndrome

[The Mechanistic Rote of KCNH2 Gene L413P and L559H Mutations in Long QT Syndrome].

Molecular Insights into the Rescue Mechanism of an hERG Activator Against Severe LQT2 Mutations.

A Novel Deletion-Frameshift Mutation in the S1 Region of HERG Gene in a Chinese Family with Long QT Syndrome.

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Radiological assessment of the effects of splinting on early hip development: Results from a randomised controlled trial of abduction splinting vs sonographic surveillance

Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Mutations In Cytoplasmic Loops Of The Kcnq1 Channel And The Risk Of Life-Threatening Events Implications For Mutation-Specific Response To Beta-Blocker Therapy In Type 1 Long-Qt Syndrome

Enhanced Store Overload–Induced Ca 2+ Release and Channel Sensitivity to Luminal Ca 2+ Activation Are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death

Electrophysiological characterization of a small molecule activator on human ether-a-go-go-related gene (hERG) potassium channel.